S1E65 - Why Clinical Trials Are the Most Expensive Capital Outlay for Startups with Rob Bedford, CEO of Franklyn Health

Early planning prevents expensive corrections when startups address clinical strategy, regulatory pathways, and cybersecurity requirements from day one rather than improvising solutions before launch. FDA pre-submission meetings provide feedback that de-risks strategies before execution.

Clinical trial design shapes feasibility for startups with limited budgets. Understanding target markets determines sample requirements since United

States sales need United States samples while Korean sales need Korean data. Reverse engineering where you want to sell enables appropriate planning.

Good Clinical Practice guidelines establish responsibility layers. Manufacturers remain accountable for outcomes even when delegating work to CROs or...